The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a …
C Edlund, A Ternhag, GS Ståhlgren… - The Lancet Infectious …, 2022 - thelancet.com
Background Use of third-generation cephalosporins, such as cefotaxime, is associated with
an increased risk of selection for antimicrobial resistance, so alternative antibiotics need to …
an increased risk of selection for antimicrobial resistance, so alternative antibiotics need to …
Temocillin against Enterobacteriaceae isolates from community-acquired urinary tract infections: low rate of resistance and good accuracy of routine susceptibility …
K Alexandre, M Réveillon-Istin, R Fabre… - Journal of …, 2018 - academic.oup.com
Background Temocillin is an old 'revived'antibiotic that may play an important role in the
treatment of febrile urinary tract infection (UTI). Data regarding its activity against current …
treatment of febrile urinary tract infection (UTI). Data regarding its activity against current …
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double …
F Wagenlehner, CR Perry, TM Hooton… - The Lancet, 2024 - thelancet.com
Background Gepotidacin is a novel, bactericidal, first-in-class triazaacenaphthylene
antibiotic that inhibits bacterial DNA replication by a distinct mechanism of action and a …
antibiotic that inhibits bacterial DNA replication by a distinct mechanism of action and a …
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind …
FM Wagenlehner, O Umeh, J Steenbergen, G Yuan… - The Lancet, 2015 - thelancet.com
Background Treatment of complicated urinary-tract infections is challenging due to rising
antimicrobial resistance. We assessed the efficacy and safety of ceftolozane-tazobactam, a …
antimicrobial resistance. We assessed the efficacy and safety of ceftolozane-tazobactam, a …
Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection
JE Stalenhoef, C van Nieuwkoop, DC Wilson… - BMC infectious …, 2019 - Springer
Background A reduction in duration of antibiotic therapy is crucial in minimizing the
development of antimicrobial resistance, drug-related side effects and health care costs. The …
development of antimicrobial resistance, drug-related side effects and health care costs. The …
Effectiveness of fosfomycin for the treatment of multidrug-resistant Escherichia coli bacteremic urinary tract infections: a randomized clinical trial
J Sojo-Dorado, I López-Hernández… - JAMA network …, 2022 - jamanetwork.com
Importance The consumption of broad-spectrum drugs has increased as a consequence of
the spread of multidrug-resistant (MDR) Escherichia coli. Finding alternatives for these …
the spread of multidrug-resistant (MDR) Escherichia coli. Finding alternatives for these …
Effect of meropenem-vaborbactam vs piperacillin-tazobactam on clinical cure or improvement and microbial eradication in complicated urinary tract infection: the …
KS Kaye, T Bhowmick, S Metallidis, SC Bleasdale… - Jama, 2018 - jamanetwork.com
Importance Meropenem-vaborbactam is a combination carbapenem/beta-lactamase
inhibitor and a potential treatment for severe drug-resistant gram-negative infections …
inhibitor and a potential treatment for severe drug-resistant gram-negative infections …
Temocillin versus carbapenems for urinary tract infection due to ESBL-producing Enterobacteriaceae: a multicenter matched case-control study
T Delory, S Gravier, D Le Pluart, G Gaube… - International Journal of …, 2021 - Elsevier
Objectives To compare the efficacy of temocillin with carbapenems for extended spectrum β-
lactamase (ESBL)-producing Enterobacteriaceae urinary tract infections (ESBL-E UTI) …
lactamase (ESBL)-producing Enterobacteriaceae urinary tract infections (ESBL-E UTI) …
The efficacy of pivmecillinam in oral step-down treatment in hospitalised patients with E. coli bacteremic urinary tract infection; a single-arm, uncontrolled treatment …
BÅ Hansen, N Grude, M Lindbæk, T Stenstad - BMC Infectious Diseases, 2022 - Springer
Background The role of oral beta-lactam antibiotics in treating febrile urinary tract infections
(UTI) is not yet definite. Today, fluoroquinolones together with trimethoprim …
(UTI) is not yet definite. Today, fluoroquinolones together with trimethoprim …
Bacteriology in uncomplicated urinary tract infections in Norwegian general practice from 2001–2015
M Bollestad, I Vik, N Grude, HS Blix, H Brekke… - BJGP open, 2018 - bjgpopen.org
Background Uncomplicated urinary tract infections in women are common, and urine
samples from these patients are not routinely cultured. Empirical treatment is based on …
samples from these patients are not routinely cultured. Empirical treatment is based on …